Fiche du document
- doi: 10.1055/s-0040-1721733
- issn: 2512-9465
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1055/s-0040-1721733
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33469565
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2512-9465
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_40479FDB0A113
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Mots-clés
anticoagulant prophylaxis; autoimmune hemolytic anemia; complication; venous thromboembolismSujets proches
Hemolytic disorder, Autoimmune Autoimmune hemolytic anemia Autoimmune hemolytic disorderCiter ce document
D. Solari et al., « Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider. », Serveur académique Lausannois, ID : 10.1055/s-0040-1721733
Métriques
Partage / Export
Résumé
Autoimmune hemolytic anemia (AIHA) is increasingly recognized as a strong risk factor for venous thrombosis. However, there are currently no guidelines on thromboembolism prevention and management during AIHA. Here, we describe the case of a patient with AIHA and pulmonary embolism and resume the current knowledge on epidemiology, risk factors, treatment, and pathophysiology of thrombosis during AIHA, as well as new therapeutic perspectives to prevent thrombus formation during AIHA.